PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus

References

• Yap, D. Y. H., and K. N. Lai. 2013. The role of cytokines in the pathogenesis of systemic lupus erythematosus – from bench to bedside. Nephrology 18: 243–255
   PubMed Web of Science ®Google Scholar
• Rezaei, A., V. Ziaee, F. T. Sharabian, et al. 2015. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin. Rheumatol. 34: 1059–1064
   PubMed Web of Science ®Google Scholar
• Velazquez-Cruz, R., L. Orozco, F. Espinosa-Rosales, et al. 2007. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur. J. Hum. Genet. 15: 336–341
   PubMed Web of Science ®Google Scholar
• Prokunina, L., C. Castillejo-Lopez, F. Oberg, et al. 2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32: 666–669
   PubMed Web of Science ®Google Scholar
• Wang, Q., D. Ye, J. Yin, et al. 2008. Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese. Arch. Dermatol. Res. 300: 91–93
   PubMed Web of Science ®Google Scholar
• Ferreiros-Vidal, I., J. J. Gomez-Reino, F. Barros, et al. 2004. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 50: 2590–2597
   PubMed Web of Science ®Google Scholar
• Jiao, Q., C. Liu, Z. Yang, et al. 2014. Upregulated PD-1 expression is associated with the development of systemic lupus erythematosus, but not the PD-1.1 allele of the PDCD1 gene. Int. J. Genomics 2014: 950903
   PubMedGoogle Scholar
• Kristjansdottir, H., K. Steinsson, I. Gunnarsson, et al. 2010. Lower expression levels of the programmed death 1 receptor on CD4 + CD25 + T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus. Arthritis Rheum. 62: 1702–1711
   PubMed Web of Science ®Google Scholar
• Johansson, M., L. Arlestig, B. Moller, and S. Rantapaa-Dahlqvist. 2005. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum. 52: 1665–1669
   PubMed Web of Science ®Google Scholar
• Kong, E. K., L. Prokunina-Olsson, W. H. Wong, et al. 2005. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum. 52: 1058–1062
   PubMed Web of Science ®Google Scholar
• Prokunina, L., L. Padyukov, A. Bennet, et al. 2004. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 50: 1770–1773
   PubMed Web of Science ®Google Scholar
• Tahoori, M. T., A. A. Pourfathollah, M. Akhlaghi, et al. 2011. Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients. Clin. Exp. Rheumatol. 29: 763–767
   PubMed Web of Science ®Google Scholar
• Liu, C., J. Jiang, L. Gao, et al. 2014. A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the han Chinese Population of Southeastern China. Int. J. Genomics 2014: 247637
   Google Scholar
• Thorburn, C. M., L. Prokunina-Olsson, K. A. Sterba, et al. 2007. Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun. 8: 279–287
   PubMed Web of Science ®Google Scholar
• Sanghera, D. K., S. Manzi, F. Bontempo, et al. 2004. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum. Genet. 115: 393–398
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
   PubMed Web of Science ®Google Scholar
• Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 57: 289–300
   Google Scholar
• Shi, Y. Y., and L. He. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15: 97–98
   PubMed Web of Science ®Google Scholar
• Ni, J., M. Zhang, Y. Zhu, et al. 2014. Association study of interleukin-19 rs2243188 polymorphism with systemic lupus erythematosus in a Chinese population. Autoimmunity. 47: 378–382
   PubMed Web of Science ®Google Scholar
• Baca, V., R. Velazquez-Cruz, G. Salas-Martinez, et al. 2006. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun. 7: 693–695
   PubMed Web of Science ®Google Scholar
• Liao, C. H., T. C. Yao, H. T. Chung, et al. 2004. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J. Rheumatol. 31: 2062–2067
   PubMed Web of Science ®Google Scholar
• Mahmoudi, M., F. Tahghighi, V. Ziaee, et al. 2014. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int. J. Immunogenet. 41: 512–517
   PubMed Web of Science ®Google Scholar
• Ziaee, V., F. Tahghighi, M. H. Moradinejad, et al. 2014. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur. Cytokine. Netw. 25: 35–40
   PubMed Web of Science ®Google Scholar
• Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677–704
   PubMed Web of Science ®Google Scholar
• Nishimura, H., M. Nose, H. Hiai, et al. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141–151
   PubMed Web of Science ®Google Scholar
• Okazaki, T., and T. Honjo. 2007. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19: 813–824
   PubMed Web of Science ®Google Scholar
• Ferreiros-Vidal, I., S. D'Alfonso, C. Papasteriades, et al. 2007. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun. 8: 138–146
   PubMed Web of Science ®Google Scholar
• Bertsias, G. K., M. Nakou, C. Choulaki, et al. 2009. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum. 60: 207–218
   PubMed Web of Science ®Google Scholar